Embecta Corp. (EMBC)
NASDAQ: EMBC · Real-Time Price · USD
9.96
-0.20 (-1.97%)
At close: Aug 1, 2025, 4:00 PM
9.93
-0.03 (-0.30%)
After-hours: Aug 1, 2025, 5:09 PM EDT

Company Description

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes in the United States and internationally.

The company’s products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient’s diabetes.

It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

Embecta Corp.
Embecta logo
CountryUnited States
Founded1924
IndustryMedical Instruments & Supplies
SectorHealthcare
Employees2,100
CEODevdatt Kurdikar

Contact Details

Address:
300 Kimball Drive, Suite 300
Parsippany, New Jersey 07054
United States
Phone862 401 0000
Websiteembecta.com

Stock Details

Ticker SymbolEMBC
ExchangeNASDAQ
Stock TypeCommon Stock
Fiscal YearOctober - September
Reporting CurrencyUSD
CIK Code0001872789
CUSIP Number29082K105
ISIN NumberUS29082K1051
Employer ID87-1583942
SIC Code3841

Key Executives

NamePosition
Devdatt Kurdikar Ph.D.President, Chief Executive Officer and Director
Jacob P. ElguiczeSenior Vice President and Chief Financial Officer
Jeffrey Z. MannSenior Vice President, General Counsel, Head of Business Development and Corporate Secretary
Jean M. CasnerSenior Vice President and Chief Human Resources Officer
Shaun CurtisSenior Vice President of Global Manufacturing and Supply Chain
Anthony M. RothVice President, Chief Accounting Officer and Corporate Controller
Colleen RileySenior Vice President and Chief Technology Officer
Pravesh KhandelwalVice President and Head of Investor Relations
Ginny BlockiSenior Vice President of Global Marketing and Product Management
Tom BlountSenior Vice President and President of North America

Latest SEC Filings

DateTypeTitle
Jul 29, 2025SCHEDULE 13G/AFiling
Jul 18, 2025SCHEDULE 13G/AFiling
May 30, 2025SDForm - SD
May 22, 20258-KCurrent Report
May 15, 2025SCHEDULE 13G/AFiling
May 13, 2025SCHEDULE 13G/AFiling
May 9, 202510-QQuarterly Report
May 9, 20258-KCurrent Report
Feb 14, 20258-KCurrent Report
Feb 13, 2025144Filing